Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
Amylmetacresol; 2,4-Dichlorobenzyl alcohol
Reckitt Benckiser Ireland Ltd
R02AA; R02AA03
Amylmetacresol; 2,4-Dichlorobenzyl alcohol
0.6 mg/1.2 milligram(s)
Lozenge
Product not subject to medical prescription
Antiseptics; dichlorobenzyl alcohol
Marketed
1986-10-16
LOT: DO NOT USE AFTER: 24 lozenges Soothing effective relief for sore throats Honey & Le mon Honey & Le mon Honey & Le mon Honey & Le mon Honey & Le mon Honey & Le mon Honey & Le mon Honey & Le mon Honey & Le mon Honey & Le mon Honey & Le mon Honey & Le mon Honey & Le mon Honey & Le mon Honey & Le mon Honey & Le mon Honey & Le mon Honey & Le mon Honey & Le mon Honey & Le mon Honey & Le mon Honey & Le mon Honey & Le mon Honey & Le mon LOZENGES LOZENGES LOZENGES Amylmetacresol 0.6mg 2,4-Dichlorobenzyl Alcohol 1.2mg _DUAL_ anti-bacterial action LOZENGES LOZENGES LOZENGES LOZENGES LOZENGES LOZENGES LOZENGES LOZENGES LOZENGES • Remember young children can choke on lozenges. • Like all medicines, this medicine can cause side effects, although not everybody gets them. Side effects may include rash, stomach pain, feeling sick, oral discomfort, rash, allergic reaction. • Consult your doctor if symptoms persist, or anything unusual happens. Do not take for more than 3 days unless told to do so by your doctor. • Contains 0.976g glucose, 1.441g sucrose, 0.3854g fructose per dose. This should be taken into account in patients with diabetes mellitus. • Do not use after the expiry date shown on the pack. • Consult your doctor or pharmacist if you are pregnant or breastfeeding. KEEP ALL MEDICINES OUT OF THE REACH AND SIGHT OF CHILDREN. Do not store above 25ºC. PA 979/38/2 Active Ingredients: 2,4-Dichlorobenzyl alcohol 1.2mg, Amylmetacresol 0.6mg. Also contains: Sucrose, Glucose Syrup, Honey, Tartaric Acid, Peppermint Oil, Terpeneless Lemon Oil and Quinoline Yellow (E104). Each lozenge contains 1g of glucose and 1.4g of sucrose. ® HONEY AND LEMON LOZENGES provide fast, soothing and effective relief from the discomfort of sore throats. Each lozenge contains a combination of 2 anti-bacterials to help kill the bacteria which can cause sore throats and mouth infections. Natural honey with lemon for an extra soothing effect on the throat. HOW TO USE: Strepsils Lozenges are suitable for adults and children over 6 years. D Read the complete document
Health Products Regulatory Authority 16 July 2021 CRN00C5NY Page 1 of 5 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Strepsils Honey & Lemon Lozenges Amylmetacresol 0.6mg 2,4-Dichlorobenzyl alcohol 1.2mg 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each lozenge contains Amylmetacresol 600 micrograms and 2, 4-Dichlorobenzyl alcohol 1.2 mg. Excipients with known effects: Glucose 0.98 g (976 mg)/lozenge. Sucrose 1.44 g (1441 mg)/lozenge. Invert Sugar (honey) 100.9 mg/lozenge. Wheat Starch (containing gluten present in liquid glucose) 19.52 micrograms/lozenge. Sulphites - Sulphur Dioxide (E220) present in liquid glucose 0.125 ppm/lozenge. Lemon flavour fragrance containing citral, d-Limonene, geraniol and linalool. For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Lozenge A yellow circular lozenge with a taste of honey and lemon, embossed on both sides with Strepsils brand icon. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS For the symptomatic relief of mouth and throat infections. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posolgy The lowest effective dose should be used for the shortest duration necessary to relieve symptoms. It is recommended that the product should be used for a maximum of 3 days. Adults:One lozenge to be dissolved slowly in the mouth every 2 – 3 hours. Do not take more than 12 lozenges in 24 hours. Paediatric population Children over 6 years of age: As above for adults. Children under 6 years of age: Not suitable for children under 6 years (see section 4.4. Elderly: There is no need for dosage reduction in the elderly. Method of administration For oromucosal administration. To be dissolved slowly in the mouth. 4.3 CONTRAINDICATIONS Hypersensitivity to the active substances or to any of the excipients listed in section 6.1. Health Products Regulatory Authority 16 July 2021 CRN00C5NY Page 2 of 5 Patients with rare hereditary problems of fructose intolerance, glucose, galactose malabsorption or sucrose-isomaltase insufficiency should not take this med Read the complete document